Hormone may hold key to longer life in elderly men

By Staff
|
Google Oneindia News

Washington, May 28 : A new study has shown that elderly men with higher activity of the hormone IGF-1, or insulin-growth factor, appear to have greater life expectancy and reduced cardiovascular risk.

IGF-1, a hormone similar in molecular structure to insulin, is released from the liver and plays a significant role in childhood growth and continues to have anabolic effects in adults.

For the study, researchers evaluated 376 healthy elderly men between the ages of 73 and 94 years.

A serum sample was taken from each participant at the beginning of the study and researchers were contacted about the status of the subjects over a period of eight years.

The study showed that subjects with the lowest IGF-1 function had a significantly higher mortality rate than subjects with the highest IGF-1 bioactivity.

These findings were especially important for individuals who have a high risk to die from cardiovascular complications.

These new findings come as a result of a new form of testing for IGF-bioactivity.

In this study, researchers used a new method, a bioassay, to measure the function of IGF-1 in the blood.

Contrary to commonly used methods to measure IGF-1, the IGF-1 bioassay gives more information about the actual function (bioactivity) of circulating IGF-1 in the body.

"The bioassay allowed us to more clearly see the association between high circulating IGF-1 bioactivity and extended survival," said Michael Brugts, MD, of the Erasmus Medical Center in Rotterdam, The Netherlands and lead author of the study.

"Interestingly, we could not find such a relationship when IGF-1 in blood was measured with the more commonly used methods," he added.

Immunoassays, commonly used previously to determine IGF-1 circulation levels, remove certain proteins that interfere with accurate measurements. Recent studies however have found that these proteins are important modulators of IGF-1 bioactivity.

The bioassay used in this study does not disregard or remove this protein, thus enabling researchers to have a more accurate understanding of IGF-1 function.

Brugts said that determination of IGF-1 function using the bioassay opens the possibility to gather new insights about the functions of IGF-1 in the body.

The study is published in the Journal of Clinical Endocrinology and Metabolism (JCEM).

ANI

For Daily Alerts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X